Sept 13, 2012 Update
There have been a number of recent sketchy media reports on NPR and the NY Times (Sept. 3, 2014) etc on a new Dengue virus vaccine from Sanofi. Unfortunately, company press releases and media reports really don’t contain sufficient details to understand the Sanofi study results. Here are one public health scientist’s views.
Full article at: Dengue News: Dengue Virus Sanofi Vaccine Trial Report – The Article
The Good News:
~ The new Sanofi vaccine appears to work well against 3 of the 4 strains (serotypes) of Dengue Virus: DV1, DV3, & DV4.
~ This is big news, because no previous attempts at Dengue vaccines have worked against even one strain of Dengue Virus.
~ The ability to give some protection from 3 out of 4 could help people in some areas. . . .
. . .
The Bad News:
~ The new Sanofi virus showed no statistically significant difference in reducing Dengue infection is a Phase 2 trial in Thailand using 4002 school children.
~ Strain 2 of Dengue Virus is the strain that has been causing the worst symptoms.
~ Strain 2 of Dengue Virus is very prevalent here in Yucatan. . . . .
If readers want more information on Dengue Treatment, Dengue virus life cycles, Dengue prevention, and Mosquito prevention, please see our Dengue Fact sheet at: Dengue Fact Sheet – May 2012 Update ~ and also click on the “Science, Tech, and Health” button (above) to read more details.
. . .
See the full article at: Dengue News: Dengue Virus Sanofi Vaccine Trial Report – The Article
* * * *
Feel free to copy while giving proper attribution: YucaLandia/Surviving Yucatan.
© Steven M. Fry
Read on, MacDuff.